Skip to Main Content

Paper Details

Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.
Blood
87
2016
AML, AML clone, acute myelogenous leukemia, hematopoietic population, leukemia, leukemia-gene panels, leukemia-related populations, myelodysplastic syndromes, nonleukemic hematopoietic clones, nonleukemic hematopoietic population, nonleukemic hematopoietic stem and progenitor cells, patient, patients
Author NameAffiliation
Christopher A MillerMcDonnell Genome Institute, Washington University School of Medicine
Jeffery M KlcoSt. Jude Children's Research Hospital
Robert S FultonMcDonnell Genome Institute
Robert S FultonMcDonnell Genome Institute
Sharon E Heath
Elaine R MardisMcDonnell Genome Institute, and Siteman Cancer Center, Washington University
Elaine R MardisMcDonnell Genome Institute, and Siteman Cancer Center, Washington University
Peter WesterveltSiteman Cancer Center, Washington University
John F DiPersioSiteman Cancer Center, Washington University
Matthew J WalterSiteman Cancer Center, Washington University
Timothy A GraubertMassachusetts General Hospital
Richard K WilsonMcDonnell Genome Institute, and Siteman Cancer Center, Washington University
Richard K WilsonMcDonnell Genome Institute, and Siteman Cancer Center, Washington University
Timothy J LeySiteman Cancer Center, Washington University
Daniel C LinkSiteman Cancer Center, Washington University
  • 1 - 15

Datasets

Release 1.2